As science races toward automation and quick experiments, it is sometimes required to concurrently handle small amounts of liquids (droplets), from picoliters to microliters. Moreover, droplet jumping ...
Sepsis arises from infection and immune dysregulation. Neutrophils play a key role in its progression, yet existing clinical tools cannot simultaneously isolate these cells and measure their ...
In a recent review article published in the journal Microsystems & Nanoengineering, researchers explored the advancements in microfluidic technologies for monitoring the electromechanical activity of ...
This collection highlights recent publications in Nature Communications on microfluidic advances: both technical improvements and those with exciting biological applications. We showcase the areas ...
Wearable sweat sensors with various sensing systems can provide noninvasive medical diagnostics and healthcare monitoring. Here, we demonstrate a wearable microfluidic nanoplasmonic sensor capable of ...
Preclinical research and development are the cornerstone of modern drug discovery. A variety of biological systems including in vitro, 3D cultures, and organoids are essential tools, with ultimately ...
Researchers at the University of Toronto's Faculty of Applied Science & Engineering have designed a new microfluidic platform that allows for unprecedented control and manipulation of tumor shapes—a ...
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
Making its latest foray into the microfluidics ring, Hopkinton, Mass.-based Caliper Life Sciences https://www.caliperls.com has introduced the new LabChip 3000 Drug Discovery System, a ...
SAN FRANCISCO--(BUSINESS WIRE)--Miroculus, Inc., developer of revolutionary tools for personal lab automation, today announced its partnership with Element Biosciences, Inc., developer of the AVITI ...
Organoid-on-chip technology merges patient-derived organoids with microfluidic engineering to recreate human physiology and predict drug responses with high precision. This innovation is reshaping ...
AI has designed candidate drugs for antibiotic-resistant infections and genetic diseases. But efforts to incorporate AI into the design of lipid nanoparticles (LNPs), the revolutionary delivery ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results